Clinical Trial: A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07089888) titled 'A Study of Dotinurad Versus Allopurinol in Tophaceous Gout' on July 22.

Brief Summary: The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with tophaceous gout.

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Tophaceous Gout

Intervention: DRUG: Allopurinol

Over-encapsulated tablets containing active drug substance administered orally (PO).

DRUG: Dotinurad

Over-encapsulated tablets containing active drug substance administered PO.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Crystalys The...